Literature DB >> 15692785

MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.

Akihiro Araki1, Takanori Kanai, Takahiro Ishikura, Shin Makita, Koji Uraushihara, Ryoichi Iiyama, Teruji Totsuka, Kiyoshi Takeda, Shizuo Akira, Mamoru Watanabe.   

Abstract

BACKGROUND: Gut commensal microbes affect the development and activation of the mucosal and systemic immune systems. However, the exact molecular mechanism of these microbes that is involved in the development of colitis remains unclear.
METHODS: The present study was conducted to determine the distinct role of the innate immune system in the development of a dextran sulfate sodium (DSS) colitis model in MyD88(-/-) mice, because myeloid differentiation protein (MyD88) is a major adaptor molecule essential for signaling via Toll-like receptors (TLRs). To this end, MyD88(-/-) and wild-type (WT) mice received sterile distilled water containing 1.2% DSS for 8 days. The survival rate, total clinical score (body weight loss, stool consistency, and rectal bleeding), colon length, and histological score were assessed. The expression of surface markers (F4/80 and CD4) on infiltrating lamina propria mononuclear cells was analyzed immunohistochemistrically.
RESULTS: MyD88(-/-) mice exhibited increased susceptibility to DSS-induced colitis, as reflected by significantly higher lethality and higher clinical and histological scores, and more severe colonic shortening compared to WT mice. Immunohistochemical analysis revealed a significant increase of both F4/80+ macrophages and CD4+ T cells in the inflamed mucosa in DSS-fed MyD88(-/-) mice compared to DSS-fed WT mice.
CONCLUSIONS: These findings suggest that, via MyD88 signaling, the innate immune system in the gut plays an important protective role in colitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15692785     DOI: 10.1007/s00535-004-1492-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  100 in total

Review 1.  Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.

Authors:  Aya M Westbrook; Akos Szakmary; Robert H Schiestl
Journal:  Mutat Res       Date:  2010-03-16       Impact factor: 2.433

Review 2.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

3.  The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis.

Authors:  Tere M Williams; Rachel A Leeth; Daniel E Rothschild; Sheryl L Coutermarsh-Ott; Dylan K McDaniel; Alysha E Simmons; Bettina Heid; Thomas E Cecere; Irving C Allen
Journal:  J Immunol       Date:  2015-02-27       Impact factor: 5.422

Review 4.  Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger.

Authors:  Charlotte E Egan; Sara B Cohen; Eric Y Denkers
Journal:  Immunol Cell Biol       Date:  2011-11-08       Impact factor: 5.126

Review 5.  Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2.

Authors:  E Cario
Journal:  Gut       Date:  2005-04-19       Impact factor: 23.059

Review 6.  Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.

Authors:  Akira Andoh; Yoshihide Fujiyama
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

7.  Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.

Authors:  A Grabig; D Paclik; C Guzy; A Dankof; D C Baumgart; J Erckenbrecht; B Raupach; U Sonnenborn; J Eckert; R R Schumann; B Wiedenmann; A U Dignass; A Sturm
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

8.  Prostaglandin-secreting cells: a portable first aid kit for tissue repair.

Authors:  Seth Rakoff-Nahoum; Ruslan Medzhitov
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

9.  Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury.

Authors:  Sarah L Brown; Terrence E Riehl; Monica R Walker; Michael J Geske; Jason M Doherty; William F Stenson; Thaddeus S Stappenbeck
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

10.  Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization.

Authors:  Y Nakanishi; T Sato; T Ohteki
Journal:  Mucosal Immunol       Date:  2014-06-18       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.